RxDoctor Payments Data

Kyle Lindow, DPM

Foot & Ankle Surgery · Slaughter, LANPI 1780049494

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,384 of the $8,456 with a category attached, or 63.7%. 27 manufacturers reported payments, led by Organogenesis Inc. at 27.4% of the total.

$8,456in general payments, 2019–2025

Across 188 payments — averaging $44.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organogenesis Inc.$2K
  • Orthofix Medical, Inc.$1K
  • Treace Medical Concepts, Inc.$1K
  • Paratek Pharmaceuticals, Inc.$634
  • ALON Medical Technology$511
  • Arthrex$482
  • plus $2K from 21 others

What the payments were for

  • Travel & lodging$3,07236%
  • Food & beverage$5,38464%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,456 in reported general payments places this provider in the 75th percentile of 92 foot & ankle surgery providers in Louisiana.

See all foot & ankle surgery providers in Louisiana

Medicare billing

Part B allowed, 2024
$715,229
Medicare patients
412
Services billed
2,485

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mupirocin257$1,833
Gabapentin82$809
Doxycycline Hyclate103$780
Ciclopirox39$727
Gentamicin Sulfate26$700
Terbinafine Hcl41$591
Pregabalin16$367
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen61$302
Ammonium Lactate17$289
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav26$223
Fluconazole31$209
Econazole Nitrate18$199
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen11$183
Tramadol Hcl12$183
Meloxicam57$172

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Slaughter

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →